The Founders

Kenneth KC WONG

Mr. K. Wong has nearly 30 years of all-rounded experience as an investment banker, PE investor, C-suite officer and entrepreneur, being extensively involved in corporate finance / operations.
As an investment banker from 1995 to 2000, Mr. Wong was involved in transactions with total value >US$38Bn.

From 2002 to 2008, Mr. Wong was CFO of PRC A-share listed Topsun Pharmaceutical / SVP of the Topsun Group. Notable achievements include:

  • Acquired two national pharmaceutical jewels, Yunnan Baiyao and Shanxi Guangyuyuan
  • Successfully disposed of Qidong Gaitianli (Topsun’s subsidiary) to Bayer (Germany), which was the first major pharmaceutical cross-border M&A deal in the PRC and was also then the largest transaction in PRC’s private sector

Mr. Wong founded the Keen Vision Group in 2008, mainly involved in PE investments.

Jason WONG

Mr. J. Wong currently serves as the founder and Chairman of Norwich Capital. Since 2014, Mr. J. Wong has been involved in the initiation of SPACs in the US and is one of the earliest participants from Asia in SPAC listings. As of now, Mr. J. Wong has been a leading figure in the number of SPACs initiated in the Asia region, with several of them successfully completing de-SPAC processes, earning him the title of “Asia’s SPAC Godfather” in the media (including Bloomberg) and the SPAC industry. One of the SPACs he was involved in was awarded the Best IPO Project in 2014 by an international M&A magazine, and he initiated the first Asia-based SPAC to acquire a domestic US biopharmaceutical company.

After the introduction of SPAC listing regulations in Hong Kong, Mr. J. Wong also participated in the initiation of the first batch of Hong Kong SPACs, making him an advocate for transforming Hong Kong into the “Asian SPAC hub”.

Mr. J. Wong is also a special guest and columnist for several well-known financial and economic media outlets.

Norwich Capital, as led by Mr. J. Wong, is one of the very few Asian teams in the market with successful track records in both US and Hong Kong SPAC initiation and de-SPAC processes.

Management Team

Kenneth KC WONG

  • Founder/Chairman/CEO, Keen Vision Group
  • Vice Chairman, Medera Inc.

Past Roles

  • SVP/CFO, Topsun Group/Topsun Pharmaceutical
  • Associate, AIG Investment Corporation
  • Associate Director, UBS Investment Bank
  • Intern Analyst, Morgan Stanley


  • Executive Certificate, MIT Sloan School of Management
  • B. Comm, Finance/Marketing/Entrepreneurship, McGill University





  • Founder/President/Board Member, Birchmount Network
  • Founder/Board Member, ROBOEATZ
  • Member/Advisory Board, sproos!

Past Roles

  • Director to Senior Advisor, TPG Growth and Rise
  • CFO, Water Technology Americas, LIXIL
  • CFO (Americas) to VP (Sales) to President (Americas), Grohe
  • Director (Corporate Strategy) to Finance Director (NA Innovation), Diageo


  • MBA in Finance and Strategy, University of Chicago Booth School of Business
  • B. Eng in Mechanical Engineering, McGill University

Board of Directors

Peter DING


Mr. Ding is a highly respected professional with extensive expertise in investment banking and corporate finance.

  • Vice Chairman to Senior Advisor, Greater China, Rothschild
  • Independent Director, CMBI Finance Limited

Past roles

  • Co-founding Partner, Quintus Partners
  • MD, Head of Greater China Investment Banking, Barclays PLC
  • MD, Co-head of M&A for Asia, Morgan Stanley
  • MD of Investment Banking, UBS AG
  • Chartered Accountant in England and Wales, ICAEW


  • B. Arts (Hons), English Language/Literature, Fudan University with a year at Leeds University

William CHU


Mr. Chu is an accomplished venture capitalist with a robust background in finance and entrepreneurship, having held key leadership roles in a variety of industries before venturing into early stage funds and accelerator programs.

  • Co-founder & Managing Partner, SparkLabs Fintech
  • Co-founder, SparkLabs Saudi Arabia

Past roles

  • Executive Director, Zheng He Capital
  • President, Lawman Group International
  • Key positions at: Merril Lynch, Wit Soundview, Booz-Allen & Hamilton


  • B. Arts, East Asian Studies, Harvard University

Prof. Albert YU


Prof. Yu has extensive experience in biotechnology, having held leadership positions in various organizations and founded the Guangdong-Hong Kong-Macao biotech alliance.

  • Chairman/CSO, Hai Kang Life Corp. Ltd.
  • Professor, Peking University
  • Non-executive roles in 22 companies and organizations: Biotech Advisory panel of the HKEX, biopharmaceutical companies, scientific conferences, research funds and institutes, and academic organizations

Past roles

  • Professorial roles: HKUST, Stanford University
  • Assistant researcher, UCSF


  • PhD, Pharmacology / M. Science, Anatomy, University of Sasketchewan
  • B. Science, Biochemistry, University of Sasketchewan